GlassScriptPhysician profile
Mark-Mina Ishak
NPI 1356682652
$4,821.98
in general payments reported to CMS, 2019-2025
30 companies · $1,870 in 2025
The $1,870 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $649 · 2020: $235 · 2021: $552 · 2022: $437 · 2023: $932 · 2024: $147 · 2025: $1,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,170 · Travel and Lodging: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.63 |
| Travel and Lodging | $779.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,409.86 | 2024-2025 | Myspine, Must, Mecta-C |
| Depuy Synthes Sales INC. | $1,062.88 | 2019-2025 | Symphony, X-Pac, Expedium |
| Globus Medical, INC. | $433.04 | 2022-2024 | Excelsiusgps Robotic Navigation System, Hedron Ia |
| Medtronic, INC. | $424.28 | 2022-2025 | Stealthstation S8 Platform, Kyphon Express II Kyphopak Tray, Mazor X System |
| Spineology INC. | $204.19 | 2019 | |
| Medtronic USA, INC. | $197.76 | 2019-2020 | |
| Nuvasive, INC. | $140.34 | 2019-2020 | |
| Abbott Laboratories | $131.81 | 2021-2025 | Proclaim, Eterna |
| Portola Pharmaceuticals, LLC | $127.66 | 2020 | |
| Baxter Healthcare | $96.50 | 2019-2023 | Floseal |
| Stryker Corporation | $95.71 | 2021-2023 | Sonopet Iq, Core |
| Aesculap, INC. | $76.29 | 2023 | Elan 4 |
| Boston Scientific Corporation | $51.83 | 2021 | |
| Smith+Nephew, INC. | $51.24 | 2022-2025 | Renasys Touch, Pico 14, Pico 7 |
| Intrinsic Therapeutics | $45.52 | 2022-2023 | Barricaid Acd (Annular Closure Device) |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $33.48 | 2022-2024 | Gelsyn-3 |
| Zimmer Biomet Holdings, INC. | $29.56 | 2023 | Tricera Handpiece |
| Kerecis Limited | $27.42 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimvie INC. | $22.92 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.09 | 2021 | |
| Radius Health, INC. | $17.43 | 2025 | Tymlos |
| Curonix LLC | $17.34 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Integra Lifesciences Corporation | $16.95 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.99 | 2021 | |
| Eisai INC. | $13.47 | 2021 | |
| Nevro Corp. | $13.30 | 2021 | |
| Livanova USA, INC. | $12.85 | 2020 | |
| Nalu Medical, INC. | $11.74 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $11.37 | 2021 | |
| Orthofix Medical, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark-Mina Ishak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.